title: Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
authors.forename: Bruce H
authors.initials: BH
authors.lastname: Dobkin
authors.forename: William M
authors.initials: WM
authors.lastname: Landau
authors.forename: Shirley
authors.initials: S
authors.lastname: Sahrmann
authors.forename: W
authors.initials: W
authors.lastname: Thomas Thach
authors.forename: D M
authors.initials: DM
authors.lastname: Simpson
authors.forename: J-M
authors.initials: JM
authors.lastname: Gracies
authors.forename: K
authors.initials: K
authors.lastname: Graham
authors.forename: M
authors.initials: M
authors.lastname: Hallett
authors.forename: J
authors.initials: J
authors.lastname: Miyasaki
authors.forename: M
authors.initials: M
authors.lastname: Naumann
authors.forename: B
authors.initials: B
authors.lastname: Russman
authors.forename: L
authors.initials: L
authors.lastname: Simpson
authors.forename: Y
authors.initials: Y
authors.lastname: So
mesh_terms: D001905:Botulinum Toxins / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000209:etiology; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care / Q000379:methods / Q000592:standards; D017410:Practice Guidelines as Topic; D020127:Recovery of Function / Q000187:drug effects / Q000502:physiology; D020521:Stroke / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; D001905:Botulinum Toxins